About Hande

A medical doctor and doctor of community medicine and public health, Hande Harmanci worked as a professor of public health in Marmara University, Turkey prior to joining WHO in January 2005 for improving the quality of education in health institutions and coordinating the Health Leadership Services programme. In this capacity, she worked with 5 countries in Sub-Saharan Africa to strengthen their medical education. She joined the Global Influenza Program in 2007 as the Team Leader of the Information Management, Training and Pandemic Preparedness team. Under the H1N1 (2009) pandemic response structure of WHO, she was also appointed as the Team Leader for Societal and Individual Measures Functional Team. Since 2011, she is working in the Global Hepatitis Program as a medical officer responsible for policy, strategy, advocacy, country intelligence, planning and country technical support. Dr Harmanci is also the focal point for WHO Collaborating Centers on hepatitis.

Prior to joining WHO, she served as the Deputy Director of Health Services in Istanbul in 1994-2002. Her responsibilities included coordinating the primary level health care services for approximately 550,000 inhabitants for planning, coordinating and monitoring of immunization, disease surveillance and family planning services and in-service training of health personnel. She also served as a consultant for WHO, UNICEF, Turkish Medical Association, the Institute for Higher Education of Turkey, the Ministry of Health of Turkey, and various sectors of the industry especially for technical capacity building and system setting activities. Dr Harmanci enjoys making functional pottery as a hobby.

This speaker will be presenting at the following session(s)

  • Developing a national plan on viral hepatitis

    Ballroom 2

    Day: 1 November

    Time: 15:30

    Chair: Joumana Hermez, World Health Organization and Seyed Moayed Alavian, Iran Hepatitis Network

    Presentations:

    • Developing a national plan: country examples.
      Uzbekistan: Dr. Erkin Musabaev, Ministry of Health, Uzbekistan
      Tanzania: Angelina Sijaona, Ministry of Health, Community Development, Gender, Elderly and Children, Tanzania
      Greece: Prof. George Papatheidoridis, Athens Medical School and Laiko Hospital of Athens, Greece
    • The contents and the process of developing national plans.
    • Joumana Hermez, World Health Organization
    • Streamlining national plans with the global and regional strategies.
    • Dr. Hande Harmanci, World Health Organization
    • Q & A session.

    Session objectives:

    • Learn to differentiate between national strategies and plans.
    • Identify the best processes to create national plans.
    • Use a checklist to align national plans with the Global Health Sector Strategy on Viral Hepatitis.
    • Critically appraise a national plan for comprehensiveness.
  • Strategic direction 2: interventions for impact and strategic direction 3: delivering for equity

    Golden Hall

    Day: 2 November

    Time: 09:15

    The second day of the Summit is dedicated to strategic directions 2 and 3, which cover the issues of "interventions for impact" and "delivering for equity".

    Chairs: Dr. Florence Zeh Kakanou, Ministry of Public Health, Cameroon and Dr. Saeed Hamid, The Aga Khan University, Pakistan

    Presentations:

    • 5 core interventions to reach HBV and HCV elimination.
      Dr. Hande Harmanci, World Health Organization
    • Scaling-up of treatment services in Brazil.
      Dr. Adele Benzaken, Ministry of Health, Brazil
    • Hepatitis B services – challenges and opportunities.
      Dr. Chukwuma Anyaike, Federal Ministry of Health, Nigeria
    • Continuum of interventions to prevent HBV infection at birth and in the first years of life
    • Dr. John Ward, US Centers for Disease Control and Prevention
    • Hepatitis C prevention and treatment for PWID.
      Prof. Gregory Dore, Kirby Institute, UNSW Sydney and St Vincent’s Hospital, Sydney
    • Hepatitis services for indigenous people.
      Luana Silveira de Faria, Ministry of Health, Brazil
    • Q & A session.

    Session objectives:

    • Learn areas of innovation and neglected issues.
    • Hear about the core issues for elimination and equitable access.
    • Gain an overview of the main advocacy areas and gaps.